Peninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kids

The company was supposed to hear back from the FDA next week, but the agency made a rare ahead-of-schedule decision.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks